Quality of Life Assessment of Chronic Thyroid Eye Disease (TED) Patients in the United States

Update Item Information
Identifier 20210222_nanos_posters_129
Title Quality of Life Assessment of Chronic Thyroid Eye Disease (TED) Patients in the United States
Creator Kimberly Cockerham; Noel Stuertz; Lissa Padnick-Silver
Affiliation (KC) Stanford Department of Ophthalmology, Stanford, California; (NS) (LP) Horizon Therapeutics, plc, Lake Forest, Illinois
Subject Neuro-ophthalmology & Systemic Disease (eg. MS, MG, Thyroid); Orbit/Ocular Pathology
Description TED is an orbital autoimmune disease that causes pain, dysmotility, vision-impairment, facial alterations and other debilitating sequelae. Although improvement can occur as inflammation subsides, patients often have persistent discomfort, tearing, diplopia, and facial disfigurement that includes proptosis and eyelid retraction. These sequalae can severely impact quality of life (QOL).1-3 The current survey examined QOL in 100 chronic US TED patients.
Date 2021-02
Language eng
Format application/pdf
Type Text
Source 2021 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2021: Poster Session III: Orbital and Eyelid Disorders
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2021. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6qk3d1f
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 1675919
Reference URL https://collections.lib.utah.edu/ark:/87278/s6qk3d1f
Back to Search Results